N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity

Transplant Immunology

Volumn 17, Issue 3, 2007, Pages 198-202

  Weiss, Lola ^a   Reich, Shoshana ^a   Zeira, Michael ^a   Or, Reuven ^a   Resnick, Igor B ^a   Slavin, Shimon ^a   Shapira, Michael Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Graft vs. host disease; Graft vs. leukemia; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CHIMERA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEM CELL TRANSPLANTATION;

ACETYLCYSTEINE; ADOPTIVE TRANSFER; ANIMALS; ANTIOXIDANTS; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; KILLER CELLS, LYMPHOKINE-ACTIVATED; MALE; MICE; STEM CELL TRANSPLANTATION;

EID: 33847235052     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.10.005     Document Type: Article

References (20)

1. Gillissen A., and Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 92 (1998) 609-623
2. Paterson R.L., Galley H.F., and Webster N.R. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 31 (2003) 2574-2578
3. Chyka P.A., Butler A.Y., Holliman B.J., and Herman M.I. Utility of acetylcysteine in treating poisonings and adverse drug reactions. Drug Saf 22 (2000) 123-148
4. Guru V., and Fremes S.E. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol 62 (2004) 77-83
5. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 94 (1997) 1967-1972
6. Kauffman C.A. Quandary about treatment of aspergillomas persists. Lancet 347 (1996) 1640
7. De Lucca A.J., Walsh T.J., and Daigle D.J. N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother 40 (1996) 1274-1276
8. Desai M.H., Mlcak R., Richardson J., Nichols R., and Herndon D.N. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine therapy. J Burn Care Rehabil 19 (1998) 210-212
9. Colombo A.A., Alessandrino E.P., Bernasconi P., Arcese G.W., Rabusin M., Bacigalupo A., et al. N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Transplantation 68 (1999) 1414-1416
10. Ringden O., Remberger M., Lehmann S., Hentschke P., Mattsson J., Klaesson S., et al. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant 25 (2000) 993-996
11. Hassan Z., Hellstrom-Lindberg E., Alsadi S., Edgren M., Hagglund H., and Hassan M. The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo. Bone Marrow Transplant 30 (2002) 141-147
12. Bhalla K.S., and Folz R.J. Idiopathic pneumonia syndrome after syngeneic bone marrow transplant in mice. Am J Respir Crit Care Med 166 (2002) 1579-1589
13. Slavin S., and Strober S. Spontaneous murine B-cell leukemia. Nature 272 (1978) 624-626
14. Slavin S., Weiss L., Morecki S., Bassat H.B., Leizerowitz R., Gamliel H., et al. Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia. Cancer Res 41 (1981) 4162-4166
15. Porgador A., Mandelboim O., Restifo N.P., and Strominger J.L. Natural killer cell lines kill autologous beta 2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc Natl Acad Sci U S A 94 (1997) 13140-13145
16. Zafarullah M., Li W.Q., Sylvester J., and Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60 (2003) 6-20
17. Sjoo F., Aschan J., Barkholt L., Hassan Z., Ringden O., and Hassan M. N-acetyl-l-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation. Bone Marrow Transplant 32 (2003) 349-354
18. Torihata H., Ishikawa F., Okada Y., Tanaka Y., Uchida T., Suguro T., et al. Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells. Immunology 112 (2004) 219-227
19. Bacigalupo A., Van Lint M.T., Occhini D., Gualandi F., Lamparelli T., Sogno G., et al. Increased risk of leukemia relapse with high dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 77 (1991) 1423-1428
20. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., and Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 132 (2006) 108-113